Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein-Reference-Cited by-同舟云学术

Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein

Published:2006-06 Issue:4 Volume:41 Page:1299-1302
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Lappin G.,Garner R.C.,Meyers T.,Powell J.,Varley P.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference11 articles.

1. Biopharmaceutical product approval times dropped 21% since the 1980s according to Tufts CSDD. Tufts Center for the Study of Drug Development, 11 March 2003. http://csdd.tufts.edu/.

2. Pharmaceutical biotechnology products approved within the European Union

3. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective

4. Interleukin-10 as a CNS therapeutic: the obstacle of the blood–brain/blood–spinal cord barrier

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Radiolabelled Compounds for Clinical Studies;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2020

2. Synthesis of Radiolabelled Compounds for Clinical Studies;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2017

3. Opportunities in low-level radiocarbon microtracing: applications and new technology;Future Science OA;2016-03

4. Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants;Clinical Pharmacology in Drug Development;2014-12-11

5. Directly Coupled High-Performance Liquid Chromatography–Accelerator Mass Spectrometry Measurement of Chemically Modified Protein and Peptides;Analytical Chemistry;2013-03-20